Welcome to our dedicated page for Cbd Life Science news (Ticker: CBDL), a resource for investors and traders seeking the latest updates and insights on Cbd Life Science stock.
CBD Life Sciences Inc. (CBDL) pioneers science-driven wellness solutions through cannabinoid research and innovative product development. This dedicated news hub provides investors and industry professionals with verified updates on corporate milestones, regulatory progress, and market expansions across CBDL's diverse operations.
Find authoritative coverage of press releases spanning product launches in functional mushrooms, equine health formulations, and nanotechnology-enhanced CBD products. Track financial disclosures, partnership announcements, and retail distribution developments that shape the company's position in the growing wellness sector.
Our curated collection serves as a centralized resource for understanding CBDL's impact on cannabinoid science and natural health markets. Key updates include advancements in Delta-8 edible formulations, strategic acquisitions, and quality control initiatives backed by third-party testing protocols.
Bookmark this page for direct access to CBD Life Sciences' official communications and stay informed about their role in advancing evidence-based wellness solutions for humans and animals alike.
CBD Life Sciences (CBDL) has announced the launch of its new 3000MG Pain Relief Cream, significantly stronger than its previous 1200MG version. President & CEO Lisa Nelson emphasizes the cream's effectiveness for athletes and professionals, promising immediate relief without psychotropic effects. The product targets customers like athletes and healthcare professionals, offering localized pain relief. The company is also nearing its third retail location, hinting at future revenue growth.
CBD Life Sciences (OTC PINK: CBDL) has successfully opened its second retail location, The CBD Vault, on June 12, 2021, in Scottsdale, AZ. The grand opening attracted over 200 customers, with all four new strains of Delta-8 cartridges selling out within the first hour. The company plans further expansion, with third and fourth locations in Sedona and Las Vegas, and is exploring a recreational marijuana facility. This expansion is expected to drive revenue growth as CBD Life Sciences continues to enhance its product offerings and retail presence.
CBD Life Sciences (OTC PINK:CBDL) has appointed Matthew McGee as its new Chief Marketing Officer, effective immediately. McGee brings experience in the cannabis sector and a strong background in customer marketing strategies. He aims to enhance the company's growth and expand its sales. President & CEO Lisa Nelson expressed confidence in McGee's leadership capabilities. LBC Bioscience, a subsidiary of CBD Life Sciences, is already well-stocked with high-quality CBD products, including oils and wellness items, and is poised for further market expansion.
CBD Life Sciences (OTC PINK:CBDL) announces its second retail store grand opening on June 12 in Scottsdale, AZ. CEO Lisa Nelson highlights the company’s ongoing expansion, including plans for a third location in Sedona and potential fourth on the Las Vegas Strip. The firm is capitalizing on Arizona's new recreational cannabis market, allowing it to offer premium products to a wider audience. Following recent approval for Amazon sales, CBD Life Sciences is optimistic about growth and revenue for the remainder of 2021.
CBD Life Sciences (OTC PINK:CBDL) announces the launch of two popular products on its Amazon Store: 1200MG Pain Relief Cream and CBD gummy bears (150MG and 350MG). CEO Lisa Nelson highlights the significance of entering the Amazon marketplace as a key step for the company's growth in the expanding hemp market. The company reports strong initial revenue from these products and plans to expand its offerings further. Additionally, CBD Life Sciences Inc. is exploring opportunities in Arizona's recreational cannabis market, positioning itself for future growth.
CBD Life Sciences (OTC PINK:CBDL) announced the grand opening of its Amazon store, showcasing its hemp-based products, including the new Green Tea Facial Cleanser. CEO Lisa Nelson emphasized the significance of this partnership in reaching new customers and enhancing product visibility. The company is planning to expand its product range on Amazon, which includes items like Pain Relief Roll-On and Pain Cream. Additionally, CBD Life Sciences is pursuing opportunities in Arizona's recreational cannabis market, enabling the sale of premium cannabis products to a broader customer base.
CBD Life Sciences (OTC PINK: CBDL) has outlined key developments for 2021 following the legalization of recreational cannabis in Arizona. The company plans to participate in trade shows and install vending machines to increase revenue. It aims to expand its market by selling hemp products on Amazon after securing a trademark for LBC Bioscience Inc.. Additionally, CBD Life Sciences is exploring cultivation opportunities in Arizona’s new market. Anticipated product launches and a robust online store are set to enhance their revenue streams significantly.
CBD Life Sciences (OTC PINK: CBDL) has announced the launch of its new Delta-10 Cartridges through subsidiary LBC Bioscience Inc. These cartridges are available in two strains: Sour Diesel and Blue Dream, both featuring 900MG of Delta-10. CEO Lisa Nelson reported strong sales of Delta-8 products and anticipates high demand for Delta-10, aiming to enhance their existing product line. The company is positioning itself to capitalize on Arizona's new recreational cannabis market and has identified potential cultivation sites.
CBD Life Sciences Inc. (OTC PINK:CBDL) announced its commitment to product purity by partnering with EVIO Labs for ISO 17025 accredited testing. The new testing services will cater to manufacturers, retailers, and consumers, ensuring safety with a comprehensive CBD Safety Panel. This includes tests for cannabinoid profiles, pesticides, heavy metals, and more. CEO Lisa Nelson emphasized the growing demand for tested hemp products, which could increase business opportunities. Additionally, the company is pursuing cultivation opportunities in Arizona’s recreational cannabis market.
CBD Life Sciences (OTC PINK:CBDL) announced its entry into the Kosher Market through its subsidiary, LBC Bioscience Inc. The company plans to introduce products such as CBD Gummies, CBD Mints, and CBD Enriched Tea. CEO Lisa Nelson highlighted a growing customer demand for kosher products, which aims to expand their market reach significantly. Kosher certification is a rising trend in the food industry, with the kosher market valued at $17 billion and growing at an annual rate of 15%. CBD Life Sciences is also exploring cultivation sites in Arizona's expanding recreational cannabis market.